Chemistry:Methylisopropyltryptamine

From HandWiki
Revision as of 02:10, 6 February 2024 by Smart bot editor (talk | contribs) (correction)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Methylisopropyltryptamine
MIPT.svg Methylisopropyltryptamine.png
Legal status
Legal status
  • AU: Unscheduled
  • CA: Unscheduled
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Schedule I (positional isomer of DET)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC14H20N2
Molar mass216.328 g·mol−1
3D model (JSmol)
  (verify)

N-Methyl-N-isopropyltryptamine (MiPT) is a psychedelic tryptamine, closely related to DMT, DiPT and Miprocin.

Chemistry

MiPT base, unlike many other tryptamines in their freebase form, does not decompose rapidly in the presence of light or oxygen.

In August 2019, Chadeayne et al. solved the crystal structure of MiPT fumarate.[1] Its systematic name is [2-(1H-indol-3-yl)ethyl](methyl)propan-2-ylazanium 3-carboxyprop-2-enoate. The salt consists of a protonated tryptammonium cation and a 3-carboxyacrylate (hydrogen fumarate) anion in the asymmetric unit.

Dosage

10-25 mg is usually taken orally, with effects lasting 4–6 hours.

Effects

MiPT is said to emphasize psychedelic/entheogenic effects over sensory/hallucinogenic activity. Users report strong mental effects, but few perceptual alterations.

Hyper sensitivity to sound as well

Legality

Sweden's public health agency suggested classifying MiPT as a hazardous substance, on May 15, 2019.[2]

In the United States MiPT is considered a schedule 1 controlled substance as a positional isomer of Diethyltryptamine (DET). MiPT is specifically mentioned by name in the DEA Controlled Substance Orange Book. [3]

See also

References

External links